Annual EBIT
$1.29B$199.71M-13.38%
Summary
- Current Value
- As of today, RPRX annual EBIT is $1.29B, down -13.38% on
- Historical Performance
- RPRX annual EBIT is down -9.66% over the past 3 years, and down -50.73% over the past 5 years
- All-Time High Comparison
- RPRX annual EBIT is currently -50.73% below its historical high of $2.62B set on
- 3-Year Low Comparison
- RPRX annual EBIT is +40.04% above its 3-year low of $922.89M reached on an earlier date
- Sector Comparison
- RPRX annual EBIT is higher than 95.43% of companies in Healthcare sector
EBIT Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBIT | $1.29B | -13.4% | -9.7% | -50.7% | +62.7% | |
| Quarterly EBIT | $427.16M | -41.9% | +122.2% | -16.3% | -0.9% | |
| TTM EBIT | $1.53B | -0.8% | +62.5% | -41.4% | +255.6% | |
| Price | $39.72 | +29.2% | +0.9% | -23.5% | – | |
| PE Ratio | 22.71 | +41.7% | -93.5% | +14.9% | – | |
| Annual Revenue | $2.26B | -3.9% | -1.1% | +24.8% | +37.0% | |
| Annual EPS | $1.91 | -24.5% | +28.0% | -70.2% | +99.6% | |
| Annual EBITDA | $1.29B | -13.4% | -11.1% | -51.2% | +49.9% | |
| Annual Net Income | $1.33B | -21.7% | +7.2% | -45.9% | +75.4% |
EBIT Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $1.49B | -13.4% | |
| 5Y | $1.60B | N/A | -19.0% |
| All | $2.62B | -50.7% |
EBIT Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $922.89M | N/A | +40.0% |
| 5Y | $922.89M | +40.0% | |
| All | $722.87M | +78.8% |
EBIT History
| Year | Value | Change |
|---|---|---|
| $1.29B | -13.4% | |
| $1.49B | +61.7% | |
| $922.89M | -35.5% | |
| $1.43B | -10.3% | |
| $1.60B | -39.2% |
| Year | Value | Change |
|---|---|---|
| $2.62B | +92.3% | |
| $1.36B | +45.2% | |
| $939.69M | +30.0% | |
| $722.87M | -9.0% | |
| $794.28M | - |
FAQ
What is the current annual EBIT of RPRX?
As of today, RPRX annual EBIT is $1.29B
What is 1-year change in RPRX annual EBIT?
RPRX annual EBIT is down -13.38% year-over-year
What is 3-year change in RPRX annual EBIT?
RPRX annual EBIT is down -9.66% over the past 3 years
How far is RPRX annual EBIT from its all-time high?
RPRX annual EBIT is currently -50.73% below its historical high of $2.62B set on December 31, 2019
How does RPRX annual EBIT rank versus sector peers?
RPRX annual EBIT is higher than 95.43% of companies in Healthcare sector
When is RPRX next annual earnings release?
The next annual earnings release for RPRX is on
Quarterly EBIT
$427.16M$217.36M+103.60%
Summary
- Current Value
- As of today, RPRX quarterly EBIT is $427.16M, up +103.60% on
- Historical Performance
- RPRX quarterly EBIT is down -41.89% year-over-year, and up +122.23% over the past 3 years
- All-Time High Comparison
- RPRX quarterly EBIT is currently -67.93% below its historical high of $1.33B set on
- 3-Year Low Comparison
- RPRX quarterly EBIT is +679.01% above its 3-year low of -$73.77M reached on
- Sector Comparison
- RPRX quarterly EBIT is higher than 96.07% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBIT | $427.16M | +103.6% | -41.9% | +122.2% | -16.3% | |
| Annual EBIT | $1.29B | – | -13.4% | -9.7% | -50.7% | |
| TTM EBIT | $1.53B | -16.7% | -0.8% | +62.5% | -41.4% | |
| Price | $39.72 | +9.8% | +29.2% | +0.9% | -23.5% | |
| PE Ratio | 22.71 | +9.8% | +41.7% | -93.5% | +14.9% | |
| Quarterly Revenue | $609.29M | +5.3% | +7.9% | +6.3% | +13.2% | |
| Quarterly EPS | $0.67 | +838.5% | -45.2% | +104.9% | -15.3% | |
| Quarterly EBITDA | $428.43M | +104.2% | -41.7% | +122.9% | -17.0% | |
| Quarterly Net Income | $444.21M | +390.1% | -44.9% | +101.5% | -28.8% |
Quarterly EBIT Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $534.18M | -20.0% | |
| 3Y | $735.07M | -41.9% | |
| 5Y | $744.95M | -42.7% | |
| All | $1.33B | -67.9% |
Quarterly EBIT Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $209.80M | +103.6% | |
| 3Y | -$73.77M | +679.0% | |
| 5Y | -$73.77M | +679.0% | |
| All | -$73.77M | +679.0% |
Quarterly EBIT History
FAQ
What is the current quarterly EBIT of RPRX?
As of today, RPRX quarterly EBIT is $427.16M
What is RPRX quarterly EBIT most recent change?
RPRX quarterly EBIT was up +103.60% on September 30, 2025
What is 1-year change in RPRX quarterly EBIT?
RPRX quarterly EBIT is down -41.89% year-over-year
How far is RPRX quarterly EBIT from its all-time high?
RPRX quarterly EBIT is currently -67.93% below its historical high of $1.33B set on December 31, 2019
How does RPRX quarterly EBIT rank versus sector peers?
RPRX quarterly EBIT is higher than 96.07% of companies in Healthcare sector
When is RPRX next earnings release?
The next earnings release for RPRX is on
TTM EBIT
$1.53B$307.92M-16.73%
Summary
- Current Value
- As of today, RPRX TTM EBIT is $1.53B, down -16.73% on
- Historical Performance
- RPRX TTM EBIT is down -0.76% year-over-year, and up +62.52% over the past 3 years
- All-Time High Comparison
- RPRX TTM EBIT is currently -41.86% below its historical high of $2.64B set on
- 3-Year Low Comparison
- RPRX TTM EBIT is +66.05% above its 3-year low of $922.72M reached on an earlier date
- Sector Comparison
- RPRX TTM EBIT is higher than 95.89% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBIT | $1.53B | -16.7% | -0.8% | +62.5% | -41.4% | |
| Annual EBIT | $1.29B | – | -13.4% | -9.7% | -50.7% | |
| Quarterly EBIT | $427.16M | +103.6% | -41.9% | +122.2% | -16.3% | |
| Price | $39.72 | +9.8% | +29.2% | +0.9% | -23.5% | |
| PE Ratio | 22.71 | +9.8% | +41.7% | -93.5% | +14.9% | |
| TTM Revenue | $2.35B | +1.9% | +3.7% | +4.6% | +17.1% | |
| TTM EPS | $1.75 | -23.9% | -31.6% | +50.7% | -71.2% | |
| TTM EBITDA | $1.53B | -16.7% | -0.7% | +60.7% | -41.8% | |
| TTM Net Income | $1.30B | -21.8% | -24.0% | +45.6% | -53.2% |
TTM EBIT Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $1.90B | -19.4% | |
| 3Y | $1.90B | -19.4% | |
| 5Y | $1.90B | -19.4% | |
| All | $2.64B | -41.9% |
TTM EBIT Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $1.29B | N/A | +18.6% |
| 3Y | $922.72M | N/A | +66.0% |
| 5Y | $922.72M | +66.0% | |
| All | $430.90M | +255.6% |
TTM EBIT History
FAQ
What is the current TTM EBIT of RPRX?
As of today, RPRX TTM EBIT is $1.53B
What is RPRX TTM EBIT most recent change?
RPRX TTM EBIT was down -16.73% on September 30, 2025
What is 1-year change in RPRX TTM EBIT?
RPRX TTM EBIT is down -0.76% year-over-year
How far is RPRX TTM EBIT from its all-time high?
RPRX TTM EBIT is currently -41.86% below its historical high of $2.64B set on June 30, 2020
How does RPRX TTM EBIT rank versus sector peers?
RPRX TTM EBIT is higher than 95.89% of companies in Healthcare sector
When is RPRX next earnings release?
The next earnings release for RPRX is on
EBIT Formula
EBIT = Revenue − −
Data Sources & References
- RPRX Official Website www.royaltypharma.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1802768/000180276825000114/0001802768-25-000114-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1802768/000180276825000010/0001802768-25-000010-index.htm
- RPRX Profile on Yahoo Finance finance.yahoo.com/quote/RPRX
- RPRX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/rprx